NoNO, Inc. operates as a biotherapeutics company. It engages in the research, development, and commercialization of pharmaceuticals for the treatment of common health disorders that include strokes, traumatic brain injuries, and pains. The company was founded by Michael Tymianski and Michael W. Salter in 2003 and is headquartered in Toronto, Canada.

Edge Therapeutics is a clinical-stage biotechnology company that discovers, develops and seeks to commercialize novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological conditions. EG-1962, our lead product candidate, has the potential to fundamentally improve patient outcomes and transform the management of aneurysmal subarachnoid hemorrhage, or aSAH, which is bleeding around the brain due to a ruptured brain aneurysm. EG-1964, our second product candidate, is being evaluated as a potential prophylactic treatment in the management of chronic subdural hematoma, to prevent recurrent bleeding on the surface of the brain. It was founded in 2009 and is headquartered in Berkeley Heights, New Jersey.

CELLPROTEK provides small molecule drugs for the treatment of major diseases of the central nervous system. They also create medications for acute ischemia stroke, alzheimer's disease, cardiovascular, cerebrovascular, and neurodegenerative diseases.

Industry Academic Cooperation Foundation Hallym University is a private company headquartered in the South Korea. The firm provides office support services.

Rainbow Medical Ltd. (Rainbow Medical) is an independent Israel-based private investment firm which was founded by Yossi Gross, GlenRock Israel and Efi Cohen-Arazi in 2007.\nLocated in Herzeliya Pituach, Rainbow Medical seeds and grows breakthrough medical device technology companies invented by serial entrepreneur Yossi Gross. The firm capitalizes on the experience and successful track record of Israel's medical devices industry and Rainbow's founders and management team to bring them to commercial success.

Azurity Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It focuses on the needs of patients, especially children and the elderly, requiring customized, user-friendly drug formulations. The firm?s products include Epaned, Qbrelis, Xatmep and FIRVANQ oral solutions. The company was founded in 1998 and is headquartered in Woburn, MA.

Edvince AB engages in clinical research and development services. It operates as a biotech company that focuses on a new form of emergency treatment for stroke. The company was founded by Lars Ingvar Herbert Edvinsson in 2003 and is headquartered in Lund, Sweden.

CereVasc is a medical device company focused on the development of novel, minimally invasive treatments for patients with neurological diseases. Current treatment of these patients requires an invasive, neurosurgical procedure with a documented rate of success well below the success rate for other neurosurgical interventions. The eShunt System has the potential to significantly improve patient outcomes and substantially decrease the overall cost of surgical treatment of this life-threatening condition.

EnClear Therapies is a Cambridge (USA) based life sciences company developing a device-based therapy to aid in the treatment of neurodegenerative disease and delivery and monitoring of cerebrospinal fluid (CSF). EnClear’s proprietary therapeutic platform focuses on removing toxic proteins from the CSF. The company’s first products will target improving the lives of patients with Amyotrophic Lateral Sclerosis (ALS) and Progressive Supranuclear Palsy (PSP).

Evonik Corp. manufactures specialty chemicals. It manufactures coatings and advanced fillers, construction chemicals, fine & industrial chemicals, performance materials and specialty polymers. The company's products range from sports and industrial floorings to amino acids and building protection coatings. Evonik is headquartered in Parsippany, NJ.

Norsk Hydro ASA engages in producing and supplying alumina and primary aluminum. It operates through the following segments: Hydro Bauxite & Alumina, Hydro Aluminium Metal, Hydro Extrusions, Hydro Energy, Hydro Metal Markets, and Other. The Hydro Bauxite & Alumina segment includes bauxite mining activities, production of alumina and related commercial activities, primarily the sale of alumina. The Hydro Aluminium Metal segment includes primary aluminium production and casting activities. The Hydro Extrusions segment delivers products within extrusion profiles, building systems and precision tubing, and is operating several recycling facilities, both integrated with its extrusion plants and separate plants. The Hydro Energy includes operating and commercial responsibility for Hydro's power stations in Norway, a trading and wholesale business in Brazil, and energy sourcing for Hydro’s world-wide operations. The Hydro Metal Markets includes all sales activities relating to products from primary metal plants and operational responsibility for stand-alone recyclers as well as physical and financial metal trading activities. The company was founded on December 2, 1905 and is headquartered in Oslo, Norway.

Pacira Pharmaceuticals Inc. operates as a pharmaceutical company which engages in the development and manufacturing of injectable pharmaceutical products. Pacira Pharmaceuticals Inc. was formerly known as DepoTech Corp. was formerly as SkyePharma Inc. and changed its name to Pacira Pharmaceuticals Inc. in June, 2007. The company was founded in 1989 and is based in San Diego, California. Pacira Pharmaceuticals Inc. operates as a subsidiary of Pacira, Inc.

Arbor Pharmaceuticals, operates as a specialty pharmaceutical company focusing on pediatric medicine. It engages in licensing, developing, and commercializing late-stage products for common pediatric conditions. The company's products include ZINOTIC and ZINOTIC ES, which addresses Acute Otitis Externa; NEOTIC, an otic analgesic agent for the treatment of pain and inflammation associated with Acute Otitis Media; and XYLAREX for the dietary management of Recurrent Acute Otitis Media. Its products also include Pediaderm HC Complete Kit, which is specifically developed to treat, manage, and protect the skin of children with atopic dermatitis, commonly referred to as eczema. The company markets its products specialty sales forces in the United States. Arbor Pharmaceuticals, was founded in 2006 and is based in Raleigh, North Carolina.

Zhongzhifeng (Suzhou) Medical Technology Co., Ltd., established on 2018-02-01, Business scope includes technology development in the field of medical devices,technical consulting,technology transfer,Technical Services;Production,Sales:medical instruments;Engage in the import and export of the above commodities and technologies.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Gunze Ltd. engages in the manufacture and sale of functional materials, textiles, and apparel. It operates through the following business segments: Functional Solutions, Apparel, and Lifestyle Creations. The Functional Solutions segment produces and sells functional materials, medical materials, and machineries. The Apparel segment offers clothing and textile materials. The Lifestyle Creations segment deals with commercial facility and sports club management as well as solar power generation. The company was founded by Tsurukichi Hatano on August 10, 1896 and is headquartered in Osaka, Japan.

Fu Wai Hospital, founded in 1956.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Ochsner Health System is a non-profit organization, which operates general and surgical hospitals. It provides clinical and hospital patient care for different specialties and treatments including heart and vascular, orthopedics, cancer care, men's health, pediatrics, women's services, digestive disorders, neurosciences, primary care, and organ transplants. The company was founded by Alton Ochsner, Guy Caldwell, Edgar Burns, Francis E. LeJeune Sr., and Curtis Tyrone in 1942 and is headquartered in New Orleans, LA.